Conclusion Switching from tirzepatide to semaglutide can be complex, yet it is an increasingly relevant clinical scenario
For those of us working at the intersection of longevity, cardiovascular health, and energy-based healing, it also invites a deeper conversation about how circulation, flow, and subtle energetics mirror each other
Keith Baar, PhD, and Henning Langer, PhD, discuss how GLP1induced weight loss interacts with exercise, aging, immobilization, and connective tissue adaptation, with particular attention to tendon health, injury risk, and activity progression
The key takeaway is that the potential benefits of GLP-1 therapy may extend beyond the number on the scale, says study author Amy Sheer, MD, MPH, an associate professor of internal medicine at the University of Florida College of Medicine in Gainesville
Anti-aging effects via SIRT1 activation
Light dressing keeps calories reasonable